B Alexander Yi Selected Research

Hemorrhage

1/2022	Pharmacokinetics and pharmacodynamics of Abelacimab (MAA868), a novel dual inhibitor of Factor XI and Factor XIa.
12/2021	Abelacimab for Prevention of Venous Thromboembolism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

B Alexander Yi Research Topics

Disease

2	Hemorrhage 01/2022 - 12/2021
2	Atrial Fibrillation 01/2022 - 04/2010
2	Venous Thromboembolism 12/2021 - 11/2021
1	Heart Failure 01/2018
1	Neuralgia (Stump Neuralgia) 02/2005

Drug/Important Bio-Agent (IBA)

3	abelacimabIBA 01/2022 - 11/2021
1	Enoxaparin (Lovenox)FDA LinkGeneric 12/2021
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Ion Channels (Ion Channel)IBA 04/2010
1	Imiquimod (Aldara)FDA LinkGeneric 02/2005

Therapy/Procedure

1	Knee Replacement Arthroplasty (Total Knee Replacement) 12/2021
1	Therapeutics 01/2018